Skip to main content
OpenTrials

Clinical trial condition

Neutropenia

Explore clinical trials studying Neutropenia. Study availability and eligibility vary by location and protocol.

75 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Neutropenia trial results

Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

NCT03511820

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Keelung Chang Gung Memorial Hospital Keelung, Taiwan
View Trial Details
Completed

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

NCT00945555

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +5 more
Locations
  • Pfizer Investigational Site Kayseri, Turkey, Turkey (Türkiye)
  • Pfizer Investigational Site Kocaeli, Turkey, Turkey (Türkiye)
  • Pfizer Investigational Site Ankara, Turkey (Türkiye)
  • Pfizer Investigational Site Bursa, Turkey (Türkiye)
View Trial Details
Completed

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

NCT01813721

Conditions
Agranulocytosis, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • Research Site Tweed Heads, New South Wales, Australia
  • Research Site Bendigo, Victoria, Australia
  • Research Site Shepparton, Victoria, Australia
  • Research Site Wodonga, Victoria, Australia
View all 90 locations
View Trial Details
Completed

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

NCT01459653

Conditions
Adnexal Diseases, Agranulocytosis, B-cell Lymphoma, +61 more
Locations
  • Sandoz Investigational Site Innsbruck, Austria
  • Sandoz Investigational Site Kufstein, Austria
  • Sandoz Investigational Site Leoben, Austria
  • Sandoz Investigational Site Deurne, Belgium
View all 117 locations
View Trial Details
Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

NCT01574235

Conditions
Agranulocytosis, Chemotherapy-Induced Febrile Neutropenia, Chemotherapy-induced Febrile Neutropenia (FN), +9 more
Locations
  • Hopital Louis Pasteur Colmar, Alsace, France
  • Hopital Jean Monnet Épinal, Alsace, France
  • CH Emile Muller Mulhouse, Alsace, France
  • CAC Paul Strauss Strasbourg, Alsace, France
View all 87 locations
View Trial Details
Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

NCT01344681

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations
  • Dong-A Medical Center Busan, South Korea
  • Severance Hospital Seoul, South Korea
  • Korea University Guro Hospital Seoul, South Korea
  • ASAN Medical Center Seoul, South Korea
View Trial Details

Related conditions